Perspective Therapeutics CATX
NYSE CATX
$2.75 +0.02 (+0.73%)
At close: Oct 2, 2026 · 4:00 PM EDT

Perspective Therapeutics (CATX) Asset Writedowns and Impairment (2023 - 2025)

Updated

Perspective Therapeutics (CATX) posted Asset Writedowns and Impairment of $10 million for Q4 2025, down 58.5% from $24.1 million a year earlier.

Analysis

Perspective Therapeutics (CATX) Asset Writedowns and Impairment (2023 - 2025) Analysis & Trends

  • In prior years, Perspective Therapeutics' Asset Writedowns and Impairment was $24.1 million in FY2024.
  • The Q4 2025 figure stands as the lowest quarterly Asset Writedowns and Impairment since Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Perspective Therapeutics 313.74 Mn 313.74 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 10.00 Mn
Dec 31, 2024 24.10 Mn
Dec 31, 2023 -298,000.00
API Access

Perspective Therapeutics Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=CATX&period=max&api_key=YOUR_API_KEY